SCHEMBL26764776

SCHEMBL26764776

O=CC1CC2(C1)CC(NC(=O)NCc1ccc(Cl)cc1)C2

nearest known ligand 0.60

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ EPHX1 P07099 5/20 0.60
▸ MEN1 O00255 1/20 0.53
▸ KMT2A Q03164 1/20 0.53
▸ TP53 P04637 1/20 0.49
▸ ALDH1A1 P00352 3/20 0.46
▸ MAPT P10636 3/20 0.46
▸ RAB9A P51151 5/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ HPGD P15428 2/20 0.44
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ LMNA P02545 3/20 0.43
▸ ALOX12 P18054 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ HTT P42858 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ DRD4 P21917 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26633681 0.85 EPHX1 (0.64) EPHX1MEN1KMT2ATP53ALDH1A1
SCHEMBL26764049 0.84 EPHX1 (0.63) EPHX1MEN1KMT2ATP53ALDH1A1
SCHEMBL24011130 0.84 EPHX1 (0.71) EPHX1MEN1KMT2ATP53ALDH1A1
SCHEMBL26764717 0.84 EPHX1 (0.63) EPHX1MEN1KMT2ATP53ALDH1A1
SCHEMBL26764321 0.84 EPHX1 (0.63) EPHX1MEN1KMT2ATP53ALDH1A1
SCHEMBL30288079 0.84 EPHX1 (0.59) EPHX1MEN1KMT2ATP53ALDH1A1
SCHEMBL26633777 0.83 EPHX1 (0.61) EPHX1MEN1KMT2ATP53ALDH1A1
SCHEMBL24011134 0.83 EPHX1 (0.61) EPHX1MEN1KMT2ATP53ALDH1A1
SCHEMBL24011297 0.83 EPHX1 (0.55) EPHX1MEN1KMT2ATP53ALDH1A1
SCHEMBL26764320 0.83 EPHX1 (0.68) EPHX1MEN1KMT2ATP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115843295-B NAMPT modulators 赛特凯恩蒂克公司 2025-04-15 — — CN disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
US-20230348369-A1 NAMPT MODULATORS CYTOKINETICS, INC. 2023-11-02 — — US disclosed
CN-115843295-A NAMPT modulators 赛特凯恩蒂克公司 2023-03-24 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230348369-A1 NAMPT MODULATORS NAMPT, NNT, NAPRT EPHX1 3913/4885MEN1 110/4885KMT2A 1973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback